P & G Health Ltd Reports Flat Performance in Q1 FY25, Debtors Turnover Ratio at 13.49x

Aug 22 2024 10:15 AM IST
share
Share Via
Procter & Gamble Health Ltd, a midcap pharmaceutical company, reported a flat performance in the quarter ending June 2024 with a score of 2 compared to -11 in the previous 3 months. The company's Debtors Turnover Ratio was the highest in the last five half-yearly periods, but net sales and earnings per share showed a decline. Investors are advised to hold their positions and monitor future financial reports for improvements.

Procter & Gamble Health Ltd, a midcap pharmaceutical company, recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.

According to the financial report, P & G Health Ltd has shown a flat performance in the quarter, with a score of 2 compared to -11 in the previous 3 months. However, there are some positive aspects to the company’s financials.


One of the highlights is the Debtors Turnover Ratio, which has been the highest in the last five half-yearly periods at 13.49 times. This indicates that the company has been able to settle its debtors at a faster rate.


On the other hand, there are some areas that need improvement for P & G Health Ltd. The net sales for the quarter were at Rs 283.88 crore, showing a decline of -5.74% year on year. This suggests a negative trend in the near term for the company’s sales.


Additionally, the company’s earnings per share (EPS) for the quarter were at its lowest in the last five quarters at Rs 10.11. This indicates a decline in profitability and lower earnings for shareholders.


Overall, P & G Health Ltd has shown a mixed performance in the quarter ending June 2024. Investors are advised to hold their positions and monitor the company’s future financial reports for any improvements.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News